{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:18:45Z","timestamp":1794385125645,"version":"4.9.0"},"reference-count":113,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Fondo de Investigaci\u00f3n Sanitaria-Feder"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00257"],"award-info":[{"award-number":["PI17\/00257"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01704"],"award-info":[{"award-number":["PI18\/01704"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01832"],"award-info":[{"award-number":["PI18\/01832"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"REDinREN","award":["RD16\/0009\/0030"],"award-info":[{"award-number":["RD16\/0009\/0030"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,16]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary or idiopathic focal segmental glomerulosclerosis (FSGS) is a kidney entity that involves the podocytes, leading to heavy proteinuria and in many cases progresses to end-stage renal disease. Idiopathic FSGS has a bad prognosis, as it involves young individuals who, in a considerably high proportion (\u223c15%), are resistant to corticosteroids and other immunosuppressive treatments as well. Moreover, the disease recurs in 30\u201350% of patients after kidney transplantation, leading to graft function impairment. It is suspected that this relapsing disease is caused by a circulating factor(s) that would permeabilize the glomerular filtration barrier. However, the exact pathologic mechanism is an unsettled issue. Besides its poor outcome, a major concern of primary FSGS is the complexity to confirm the diagnosis, as it can be confused with other variants or secondary forms of FSGS and also with other glomerular diseases, such as minimal change disease. New efforts to optimize the diagnostic approach are arising to improve knowledge in well-defined primary FSGS cohorts of patients. Follow-up of properly classified primary FSGS patients will allow risk stratification for predicting the response to different treatments. In this review we will focus on the diagnostic algorithm used in idiopathic FSGS both in native kidneys and in disease recurrence after kidney transplantation. We will emphasize those potential confusing factors as well as their detection and prevention. In addition, we will also provide an overview of ongoing studies that recruit large cohorts of glomerulopathy patients (Nephrotic Syndrome Study Network and Cure Glomerulonephropathy, among others) and the experimental studies performed to find novel reliable biomarkers to detect primary FSGS.<\/jats:p>","DOI":"10.1093\/ckj\/sfaa110","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:23:33Z","timestamp":1589289813000},"page":"482-491","source":"Crossref","is-referenced-by-count":27,"title":["Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers"],"prefix":"10.1093","volume":"14","author":[{"given":"Conxita","family":"Jacobs-Cach\u00e1","sequence":"first","affiliation":[{"name":"Nephrology Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"},{"name":"Department of Nephrology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"},{"name":"Red de Investigaciones Renales (RedInRen), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Vergara","sequence":"additional","affiliation":[{"name":"Nephrology Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"},{"name":"Department of Nephrology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Garc\u00eda-Carro","sequence":"additional","affiliation":[{"name":"Nephrology Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"},{"name":"Department of Nephrology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"},{"name":"Red de Investigaciones Renales (RedInRen), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Agraz","sequence":"additional","affiliation":[{"name":"Nephrology Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"},{"name":"Department of Nephrology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"},{"name":"Red de Investigaciones Renales (RedInRen), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Toapanta-Gaibor","sequence":"additional","affiliation":[{"name":"Nephrology Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"},{"name":"Department of Nephrology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Ariceta","sequence":"additional","affiliation":[{"name":"Red de Investigaciones Renales (RedInRen), Madrid, Spain"},{"name":"Department of Paediatric Nephrology, Hospital Universitari Vall d\u2019Hebron. Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Moreso","sequence":"additional","affiliation":[{"name":"Nephrology Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"},{"name":"Department of Nephrology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"},{"name":"Red de Investigaciones Renales (RedInRen), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ser\u00f3n","sequence":"additional","affiliation":[{"name":"Nephrology Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"},{"name":"Department of Nephrology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"},{"name":"Red de Investigaciones Renales (RedInRen), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"L\u00f3pez-Hell\u00edn","sequence":"additional","affiliation":[{"name":"Red de Investigaciones Renales (RedInRen), Madrid, Spain"},{"name":"Department of Biochemistry, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"},{"name":"Biochemistry Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-0766","authenticated-orcid":false,"given":"Maria Jos\u00e9","family":"Soler","sequence":"additional","affiliation":[{"name":"Nephrology Research Group, Vall d\u2019hebr\u00f3n Institut de Recerca (VHIR), Barcelona, Spain"},{"name":"Department of Nephrology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"},{"name":"Red de Investigaciones Renales (RedInRen), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"2021021623385605700_sfaa110-B1","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D'Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"2021021623385605700_sfaa110-B2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B3","first-page":"661","article-title":"Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Transplant","volume":"33","author":"O\u2019Shaughnessy","year":"2018"},{"key":"2021021623385605700_sfaa110-B4","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidnet Int Suppl"},{"key":"2021021623385605700_sfaa110-B5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.kint.2016.08.030","article-title":"Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation","volume":"91","author":"Cosio","year":"2017","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B6","doi-asserted-by":"crossref","first-page":"4632768","DOI":"10.1155\/2016\/4632768","article-title":"FSGS: diagnosis and diagnostic work-up","volume":"2016","author":"Sprangers","year":"2016","journal-title":"Biomed Res Int"},{"key":"2021021623385605700_sfaa110-B7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrneph.2016.147","article-title":"Minimal change disease and idiopathic FSGS: manifestations of the same disease","volume":"12","author":"Maas","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2021021623385605700_sfaa110-B8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"2021021623385605700_sfaa110-B9","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/ndt\/gfu355","article-title":"Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future","volume":"29","author":"Maas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2021021623385605700_sfaa110-B10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/tri.13372","article-title":"Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value \u2013 a multi-centre cohort study","volume":"32","author":"Puig-Gay","year":"2019","journal-title":"Transpl Int"},{"key":"2021021623385605700_sfaa110-B11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"2021021623385605700_sfaa110-B12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2215\/CJN.04500511","article-title":"Clinical outcomes and predictors for ESRD and mortality in primary GN","volume":"7","author":"Chou","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B14","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.ASN.0000135051.62500.97","article-title":"Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants","volume":"15","author":"Chun","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0272-6386(99)70257-X","article-title":"Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration","volume":"33","author":"Praga","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2021021623385605700_sfaa110-B16","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1681\/ASN.2016101121","article-title":"Long-term outcome of steroid-resistant nephrotic syndrome in children","volume":"28","author":"Trautmann","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1681\/ASN.V7149","article-title":"Serial morphometric analysis of sclerotic lesions in primary \u201cfocal\u201d segmental glomerulosclerosis","volume":"7","author":"Fuiano","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D\u2019Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2021021623385605700_sfaa110-B19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.2011.195","article-title":"Clinical trial of focal segmental glomerulosclerosis in children and young adults","volume":"80","author":"Gipson","year":"2011","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ki.5000160","article-title":"Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants","volume":"69","author":"Thomas","year":"2006","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ckj\/sfu100","article-title":"Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations","volume":"7","author":"Sethi","year":"2014","journal-title":"Clin Kidney J"},{"key":"2021021623385605700_sfaa110-B22","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.mayocp.2017.09.011","article-title":"The incidence of primary vs secondary focal segmental glomerulosclerosis: a clinicopathologic study","volume":"92","author":"Hommos","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2021021623385605700_sfaa110-B23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fendo.2018.00379","article-title":"Novel microscopic techniques for podocyte research","volume":"9","author":"Siegerist","year":"2018","journal-title":"Front Endocrinol"},{"key":"2021021623385605700_sfaa110-B24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fmed.2019.00037","article-title":"New views of the glomerulus: advanced microscopy for advanced diagnosis","volume":"6","author":"Pullman","year":"2019","journal-title":"Front Med"},{"key":"2021021623385605700_sfaa110-B25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort","volume":"10","author":"Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fped.2018.00200","article-title":"Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet registry","volume":"6","author":"Trautmann","year":"2018","journal-title":"Front Pediatr"},{"key":"2021021623385605700_sfaa110-B27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B28","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","article-title":"Genetic testing in steroid-resistant nephrotic syndrome: when and how?","volume":"31","author":"Lovric","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2021021623385605700_sfaa110-B29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ckj\/sfv091","article-title":"A\u00a0COL4A5\u00a0mutation with glomerular disease and signs of chronic thrombotic microangiopathy","volume":"8","author":"Wuttke","year":"2015","journal-title":"Clin Kidney J"},{"key":"2021021623385605700_sfaa110-B30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CN109737","article-title":"COL4A5\u00a0mutation causes Alport syndrome with focal segmental glomerulosclerosis lesion: case report and literature review","volume":"92","author":"Zhang","year":"2019","journal-title":"Clin Nephrol"},{"key":"2021021623385605700_sfaa110-B31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5858\/arpa.2013-0660-RS","article-title":"Renal dysplasia","volume":"139","author":"Chen","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"2021021623385605700_sfaa110-B32","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/ki.2013.508","article-title":"Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract","volume":"85","author":"Hwang","year":"2014","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B33","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2017121265","article-title":"Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract","volume":"29","author":"van der Ven","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/gfp538","article-title":"Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation","volume":"25","author":"Ponticelli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2021021623385605700_sfaa110-B35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1399-0012.2011.01452.x","article-title":"Focal segmental glomerulosclerosis after renal transplantation","volume":"25","author":"Shimizu","year":"2011","journal-title":"Clin Transplant"},{"key":"2021021623385605700_sfaa110-B36","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/TP.0b013e318250234a","article-title":"Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis","volume":"93","author":"Chang","year":"2012","journal-title":"Transplant J"},{"key":"2021021623385605700_sfaa110-B37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ajt.12045","article-title":"Recent progress in the pathophysiology and treatment of FSGS recurrence","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am J Transplant"},{"key":"2021021623385605700_sfaa110-B38","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1111\/ctr.12079","article-title":"Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation","volume":"27","author":"Shishido","year":"2013","journal-title":"Clin Transplant"},{"key":"2021021623385605700_sfaa110-B39","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1600-6143.2009.02580.x","article-title":"Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study","volume":"9","author":"Canaud","year":"2009","journal-title":"Am J Transplant"},{"key":"2021021623385605700_sfaa110-B40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/nep.13589","article-title":"Clinical features and outcomes of kidney transplant recipients with focal segmental glomerulosclerosis recurrence","volume":"24","author":"Mansur","year":"2019","journal-title":"Nephrology"},{"key":"2021021623385605700_sfaa110-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3295618","article-title":"FSGS recurrence in adults after renal transplantation","volume":"2016","author":"Rudnicki","year":"2016","journal-title":"BioMed Res Int"},{"key":"2021021623385605700_sfaa110-B42","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2215\/CJN.12571213","article-title":"De novo glomerular diseases after renal transplantation","volume":"9","author":"Ponticelli","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2215\/CJN.08370812","article-title":"Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE)","volume":"8","author":"Barisoni","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/modpathol.2016.58","article-title":"Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images","volume":"29","author":"Barisoni","year":"2016","journal-title":"Mod Pathol"},{"key":"2021021623385605700_sfaa110-B46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.semnephrol.2015.04.006","article-title":"Morphology in the digital age: integrating high-resolution description of structural alterations with phenotypes and genotypes","volume":"35","author":"Nast","year":"2015","journal-title":"Semin Nephrol"},{"key":"2021021623385605700_sfaa110-B47","doi-asserted-by":"crossref","first-page":"e0156441","DOI":"10.1371\/journal.pone.0156441","article-title":"The application of digital pathology to improve accuracy in glomerular enumeration in renal biopsies","volume":"11","author":"Rosenberg","year":"2016","journal-title":"PLoS One"},{"key":"2021021623385605700_sfaa110-B48","doi-asserted-by":"crossref","first-page":"316ra193","DOI":"10.1126\/scitranslmed.aac7071","article-title":"Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker","volume":"7","author":"Ju","year":"2015","journal-title":"Sci Transl Med"},{"key":"2021021623385605700_sfaa110-B49","doi-asserted-by":"crossref","first-page":"e122697","DOI":"10.1172\/jci.insight.122697","article-title":"Organoid single cell profiling identifies a transcriptional signature of glomerular disease","volume":"4","author":"Harder","year":"2019","journal-title":"JCI Insight"},{"key":"2021021623385605700_sfaa110-B50","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.2014111131","article-title":"Integrative genomics identifies novel associations with APOL1 risk genotypes in black NEPTUNE subjects","volume":"27","author":"Sampson","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00467-014-2857-9","article-title":"Defining nephrotic syndrome from an integrative genomics perspective","volume":"30","author":"Sampson","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"2021021623385605700_sfaa110-B52","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.kint.2016.06.020","article-title":"The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases","volume":"90","author":"Hogan","year":"2016","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B53","first-page":"494","article-title":"Correlation between the protein\/creatinine ratio in spot urine and 24-hour urine protein","volume":"32","author":"Montero","year":"2012","journal-title":"Nefrologia"},{"key":"2021021623385605700_sfaa110-B54","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2215\/CJN.00450119","article-title":"Methods for assessing longitudinal biomarkers of time-to-event outcomes in CKD","volume":"14","author":"Liu","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2215\/CJN.02560315","article-title":"Complete remission in the nephrotic syndrome study network","volume":"11","author":"Gipson","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.ajkd.2018.07.020","article-title":"CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease","volume":"73","author":"Mariani","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2021021623385605700_sfaa110-B57","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.kint.2018.12.018","article-title":"Health-related quality of life in glomerular disease","volume":"95","author":"Canetta","year":"2019","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B58","doi-asserted-by":"crossref","first-page":"e012143","DOI":"10.1161\/JAHA.119.012143","article-title":"Prevalence of cardiovascular disease risk factors in childhood glomerular diseases","volume":"8","author":"Ashoor","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2021021623385605700_sfaa110-B59","first-page":"158","article-title":"Central Committee of the Toronto Glomerulonephritis Registry. Regional program for the study of glomerulonephritis","volume":"124","year":"1981","journal-title":"Can Med Assoc J"},{"key":"2021021623385605700_sfaa110-B60","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9343(87)90155-0","article-title":"Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis","volume":"82","author":"Pei","year":"1987","journal-title":"Am J Med"},{"key":"2021021623385605700_sfaa110-B61","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-113-9-656","article-title":"Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis","volume":"113","author":"Falk","year":"1990","journal-title":"Ann Intern Med"},{"key":"2021021623385605700_sfaa110-B62","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-018-4103-3","article-title":"Correction to: recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings","volume":"34","author":"Pelletier","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"2021021623385605700_sfaa110-B63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2369-14-236","article-title":"An overview of the British Columbia Glomerulonephritis Network and Registry: integrating knowledge generation and translation within a single framework","volume":"14","author":"Barbour","year":"2013","journal-title":"BMC Nephrol"},{"key":"2021021623385605700_sfaa110-B64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2054-3581-1-17","article-title":"The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project: overview of design and methods","volume":"1","author":"Samuel","year":"2014","journal-title":"Can J Kidney Health Dis"},{"key":"2021021623385605700_sfaa110-B65","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1399-3046.2007.00704.x","article-title":"Contributions of the Transplant Registry: the 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)","volume":"11","author":"Smith","year":"2007","journal-title":"Pediatr Transplant"},{"key":"2021021623385605700_sfaa110-B66","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2215\/CJN.04260415","article-title":"Chronic Renal Insufficiency Cohort Study (CRIC): overview and summary of selected findings","volume":"10","author":"Denker","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B67","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2215\/CJN.11951214","article-title":"Human heredity and health (H3) in Africa kidney disease research network: a focus on methods in sub-Saharan Africa","volume":"10","author":"Osafo","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"2021021623385605700_sfaa110-B69","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"2021021623385605700_sfaa110-B70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI5535","article-title":"Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies","volume":"104","author":"Tomana","year":"1999","journal-title":"J Clin Invest"},{"key":"2021021623385605700_sfaa110-B71","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1053\/j.ajkd.2018.06.020","article-title":"APOL1-associated nephropathy: a key contributor to racial disparities in CKD","volume":"72","author":"Freedman","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2021021623385605700_sfaa110-B72","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B73","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ckj\/sfx143","article-title":"Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults","volume":"11","author":"Lepori","year":"2018","journal-title":"Clin Kidney J"},{"key":"2021021623385605700_sfaa110-B74","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1097\/01.ASN.0000090745.85482.06","article-title":"Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases","volume":"14","author":"Schmid","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B75","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00467-017-3775-4","article-title":"Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?","volume":"32","author":"Froes","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"2021021623385605700_sfaa110-B76","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2215\/CJN.10571011","article-title":"Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant","volume":"7","author":"Fatima","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B77","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/ki.2015.116","article-title":"Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis","volume":"88","author":"Kuppe","year":"2015","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B78","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1681\/ASN.2016121280","article-title":"Tissue-specific microRNA expression patterns in four types of kidney disease","volume":"28","author":"Baker","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nm.3142","article-title":"Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1","volume":"19","author":"Gebeshuber","year":"2013","journal-title":"Nat Med"},{"key":"2021021623385605700_sfaa110-B80","first-page":"1","article-title":"Urinary exosomal MIR-193a can be a potential biomarker for the diagnosis of primary focal segmental glomerulosclerosis in children","volume":"2017","author":"Huang","year":"2017","journal-title":"Biomed Res Int"},{"key":"2021021623385605700_sfaa110-B81","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1681\/ASN.V103552","article-title":"\u201cThe FSGS factor\u201d: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma","volume":"10","author":"Sharma","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/153537020422900111","article-title":"The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects","volume":"229","author":"Sharma","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"2021021623385605700_sfaa110-B83","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1053\/j.ackd.2014.05.010","article-title":"Permeability factors in focal and segmental glomerulosclerosis","volume":"21","author":"Reiser","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"2021021623385605700_sfaa110-B84","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ckj\/sfv090","article-title":"A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues","volume":"8","author":"Wada","year":"2015","journal-title":"Clin Kidney J"},{"key":"2021021623385605700_sfaa110-B85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"2021021623385605700_sfaa110-B86","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ki.2014.346","article-title":"A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease","volume":"87","author":"Spinale","year":"2015","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B87","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2013.544","article-title":"A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease","volume":"85","author":"Wada","year":"2014","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B88","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ki.2012.32","article-title":"Serum-soluble urokinase receptor concentration in primary FSGS","volume":"81","author":"Maas","year":"2012","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B89","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1681\/ASN.2013040425","article-title":"Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice","volume":"25","author":"Cathelin","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0000000000002930","article-title":"Further evidence that the soluble urokinase plasminogen activator receptor does not directly injure mice or human podocytes","volume":"104","author":"Harel","year":"2019","journal-title":"Transplantation"},{"key":"2021021623385605700_sfaa110-B91","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2337\/dc18-1427","article-title":"Soluble urokinase plasminogen activator receptor predicts cardiovascular events, kidney function decline, and mortality in patients with type 1 diabetes","volume":"42","author":"Rotbain Curovic","year":"2019","journal-title":"Diabetes Care"},{"key":"2021021623385605700_sfaa110-B92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10408363.2016.1269310","article-title":"The intriguing role of soluble urokinase receptor in inflammatory diseases","volume":"54","author":"Desmedt","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2021021623385605700_sfaa110-B93","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thun\u00f8","year":"2009","journal-title":"Dis Mark"},{"key":"2021021623385605700_sfaa110-B94","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cjca.2015.03.023","article-title":"suPAR: a new biomarker for cardiovascular disease?","volume":"31","author":"Hodges","year":"2015","journal-title":"Can J Cardiol"},{"key":"2021021623385605700_sfaa110-B95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.resp.2014.12.018","article-title":"The role of the soluble urokinase plasminogen activator (suPAR) in children with pneumonia","volume":"209","author":"Wrotek","year":"2015","journal-title":"Respir Physiol Neurobiol"},{"key":"2021021623385605700_sfaa110-B96","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","article-title":"Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates","volume":"96","author":"Franco Palacios","year":"2013","journal-title":"Transplant J"},{"key":"2021021623385605700_sfaa110-B97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1741-7015-12-81","article-title":"Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis","volume":"12","author":"Huang","year":"2014","journal-title":"BMC Med"},{"key":"2021021623385605700_sfaa110-B98","doi-asserted-by":"crossref","first-page":"e0217569","DOI":"10.1371\/journal.pone.0217569","article-title":"Podocin and uPAR are good biomarkers in cases of focal and segmental glomerulosclerosis in pediatric renal biopsies","volume":"14","author":"Pereira LHd","year":"2019","journal-title":"PLoS One"},{"key":"2021021623385605700_sfaa110-B99","doi-asserted-by":"crossref","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Trans Med"},{"key":"2021021623385605700_sfaa110-B100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.kint.2018.10.030","article-title":"Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients","volume":"95","author":"Srivastava","year":"2019","journal-title":"Kidney Int"},{"key":"2021021623385605700_sfaa110-B101","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0002-9440(10)64421-5","article-title":"Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation","volume":"161","author":"Saleem","year":"2002","journal-title":"Am J Pathol"},{"key":"2021021623385605700_sfaa110-B102","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41419-018-0569-y","article-title":"Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis","volume":"9","author":"Xiao","year":"2018","journal-title":"Cell Death Dis"},{"key":"2021021623385605700_sfaa110-B103","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2014.07.013","article-title":"Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis","volume":"65","author":"Zhang","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2021021623385605700_sfaa110-B104","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00467-013-2434-7","article-title":"Serum microRNAs levels in primary focal segmental glomerulosclerosis","volume":"28","author":"Cai","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"2021021623385605700_sfaa110-B105","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1681\/ASN.2006070767","article-title":"Urine biomarkers predict the cause of glomerular disease","volume":"18","author":"Varghese","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B106","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/ndt\/gfm587","article-title":"Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis","volume":"23","author":"Shui","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2021021623385605700_sfaa110-B107","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1600-6143.2012.04338.x","article-title":"A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation","volume":"13","author":"Lopez-Hellin","year":"2013","journal-title":"Am J Transplant"},{"key":"2021021623385605700_sfaa110-B108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/574261","article-title":"The novel diagnostic biomarkers for focal segmental glomerulosclerosis","volume":"2014","author":"Nafar","year":"2014","journal-title":"Int J Nephrol"},{"key":"2021021623385605700_sfaa110-B109","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00467-019-04289-5","article-title":"Urinary apolipoprotein AI in children with kidney disease","volume":"34","author":"Clark","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"2021021623385605700_sfaa110-B110","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s00467-019-04309-4","article-title":"Should high molecular weight forms of apolipoprotein A-I be analyzed in urine of relapsing FSGS patients?","volume":"34","author":"Jacobs-Cach\u00e1","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"2021021623385605700_sfaa110-B111","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2215\/CJN.11561113","article-title":"Evaluation of microRNAs miR-196a, miR-30a-5p, and miR-490 as biomarkers of disease activity among patients with FSGS","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021021623385605700_sfaa110-B112","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/eci.12420","article-title":"Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study","volume":"45","author":"Ramezani","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"2021021623385605700_sfaa110-B113","author":"Baggini","year":"2017"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/14\/2\/482\/36283886\/sfaa110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/14\/2\/482\/36283886\/sfaa110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T14:46:48Z","timestamp":1666536408000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/14\/2\/482\/5890996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":113,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,11]]},"published-print":{"date-parts":[[2021,2,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaa110","relation":{},"ISSN":["2048-8513"],"issn-type":[{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,8,11]]}}}